Early access
Sign in
Not yet taking people in SwedenPhase 1

Tests immune cell transfer with or without a vaccine in melanoma

Tests immune cell transfer, with or without vaccine, in adults with melanoma.

Key facts

Who runs it
Karolinska University Hospital
Where
Solna, SwedenSee the site
Registry title
A study of safety, feasibility and immunologic response of transfering tumor infiltrating lymphocytes with or without dendritic cell vaccination in patients with metastatic melanoma
Status
Not yet recruiting
Phase
Phase 1
People taking part
20 people, planned
Started
5 Apr 2013
Expected to end
5 Apr 2028
Type of study
Interventional
Record updated
23 January 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with advanced melanoma that has spread, with measurable tumours in internal organs. It tests tumour infiltrating lymphocytes with or without a dendritic cell vaccine.

Age
18 years or older
Sex
All sexes can join
Disease stage
Metastatic malignant melanoma, stage 3 or 4, with measurable lesions in internal organs

Where in Sweden

  • Karolinska University HospitalSolna, SwedenNot yet recruiting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Plain-language title
Tests immune cell transfer with or without a vaccine in melanomaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
23 January 2025